Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 108
- Uncategorized
Prohibition Partners Announces Strategic Partnership with the National Cannabis Industry Association (NCIA)
[London, 26/09/2023] – Prohibition Partners, a leading cannabis industry business media & data business, is pleased to announce a significant strategic partnership with the National Cannabis Industry Association (NCIA).
- Uncategorized
Wisconsin Introduces New Bill For Adult-Use Cannabis Legalisation
Wisconsin lawmakers have introduced a new bill which would legalise adult-use cannabis consumption, the possession of up to five ounces for over 21s, and remove criminal penalties for those under 21.
- Uncategorized
New Yorks Cannabis Regulators Face Fresh Lawsuit as ‘Immediate Future of Cannabis Industry Remains Uncertain’
Another new lawsuit has been filed against New York’s Office of Cannabis Management (OCM) and the Cannabis Control Board (CCB), this time led by cannabis ecommerce platform Leafly.
- Policy & Regulation
Czech Cannabis Reform: Progress, Projections, and Politics
In the first of a series of articles taking a deep dive into the market, focusing on everything from its progressive laws surrounding hemp to its supply chains and investment potential, Business of Cannabis will explore the current political climate in the country.
- Adult-Use
Positive Regulatory Developments In Portugal, Belgium And The Netherlands Show ‘Global Winds are Changing Fast’ For Cannabis Reform
Following a period of relative regulatory stagnation and mounting financial pressure, the global cannabis industry has seen a flurry of promising developments over the past month providing hope for investors and industry stakeholders alike.
- Uncategorized
Pennsylvania Medical Cannabis Growers Will Now Be Able To Sell Directly To Patients Following Senate Approval
A bill which will allow all licensed medical cannabis growers and processors in Pennsylvania to sell directly to patients has been approved by the state’s senate.
- Press releases
CB21 Pharma Successfully Extends EU GMP Certification, Reinforcing Its Position in the Pharmaceutical Industry
CB21 Pharma, a leading Czech-based pharmaceutical company specializing in producing cannabinoid ingredients and medical devices, has successfully extended its EU Good Manufacturing Practice (GMP) certification under certificate # sukls105303/2023.
- Uncategorized
Coalition of Cannabis Workers Says Passing SAFE Banking A ‘Moral Imperative’ Due to Worker Safety Fears
A group of 35 organisations including both NGOs and trade associations representing millions of workers in the US have called on congress to enact the long-awaited SAFE Banking Act this year.
- Markets & Stocks
Apollon Signs New Deal To Sell Assets, New Cannabis ETF Launches After Rescheduling News, & More From Stenocare
Apollon Formularies [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”APOL.AQ” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Aquis-listed Apollon Formularies has entered into another agreement to sell its ‘global assets’ after announcing that its previous deal with Global Hemp Group (GHG) had now fallen through.
- Uncategorized
BZAM has ‘Significantly Improved Margins’ Since Merger as Hundreds of Jobs Lost and Numerous Sites Sold
Canadian cannabis producer BZAM says it has managed to cut annual costs by $20m since its merger with The Green Organic Dutchman last year.
- Events
Big Tobacco Wants ‘Meaningful Part’ In Cannabis Industry: Key Insights from the Cannabis Business Expo 2023
Cannabis industry stakeholders from across the world were welcomed to Messe Dortmund this week for the inaugural edition of the Cannabis Business Expo 2023.
- Uncategorized
Canopy Growth Looks to Raise Up To $50m in Fresh Placement
Yesterday Canopy Growth Corporation announced that it was seeking to raise up to $50m in additional funding via a ‘private placement offering’.











